• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人支气管扩张症的微生物学随访研究。

Microbiologic follow-up study in adult bronchiectasis.

作者信息

King Paul T, Holdsworth Stephen R, Freezer Nicholas J, Villanueva Elmer, Holmes Peter W

机构信息

Department of Respiratory and Sleep Medicine, Monash Medical Centre, Clayton, Melbourne 3168, Australia.

出版信息

Respir Med. 2007 Aug;101(8):1633-8. doi: 10.1016/j.rmed.2007.03.009. Epub 2007 Apr 30.

DOI:10.1016/j.rmed.2007.03.009
PMID:17467966
Abstract

There is minimal published longitudinal data about pathogenic microorganisms in adults with bronchiectasis. Therefore a study was undertaken to assess the microbiologic profile over time in bronchiectasis. A prospective study of clinical and microbiologic outcomes was performed. Subjects were assessed by a respiratory physician and sputum sample were collected for analysis. Subjects were followed up and had repeat assessment performed. Eighty-nine subjects were followed up for a period of 5.7+/-3.6 years. On initial assessment the two most common pathogens isolated were Haemophilus influenzae (47%) and Pseudomonas aeruginosa (12%) whilst 21% had no pathogens isolated. On follow-up review results were similar (40% H. influenzae, 18% P. aeruginosa and 26% no pathogens). The prevalence of antibiotic resistance of isolates increased from 13% to 30%. Analysis of a series of H. influenzae isolates showed they were nearly all nontypeable and all were different subtypes. Subjects with no pathogens isolated from their sputum had the mildest disease, while subjects with P. aeruginosa had the most severe bronchiectasis. Many subjects with bronchiectasis are colonized with the same bacterium over an average follow-up of 5 years. Different pathogens are associated with different patterns of clinical disease.

摘要

关于支气管扩张症成年患者体内致病微生物的纵向数据发表得很少。因此,开展了一项研究来评估支气管扩张症患者随时间推移的微生物学特征。对临床和微生物学结果进行了一项前瞻性研究。由呼吸内科医生对受试者进行评估,并采集痰液样本进行分析。对受试者进行随访并重复评估。89名受试者接受了为期5.7±3.6年的随访。在初次评估时,分离出的两种最常见病原体是流感嗜血杆菌(47%)和铜绿假单胞菌(12%),而21%的受试者未分离出病原体。在随访复查时,结果相似(40%为流感嗜血杆菌,18%为铜绿假单胞菌,26%未分离出病原体)。分离菌株的抗生素耐药率从13%升至30%。对一系列流感嗜血杆菌分离株的分析表明,它们几乎都是不可分型的,且均为不同亚型。痰液中未分离出病原体的受试者病情最轻,而感染铜绿假单胞菌的受试者支气管扩张最为严重。在平均5年的随访中,许多支气管扩张症患者感染的是同一种细菌。不同的病原体与不同的临床疾病模式相关。

相似文献

1
Microbiologic follow-up study in adult bronchiectasis.成人支气管扩张症的微生物学随访研究。
Respir Med. 2007 Aug;101(8):1633-8. doi: 10.1016/j.rmed.2007.03.009. Epub 2007 Apr 30.
2
A novel microbiota stratification system predicts future exacerbations in bronchiectasis.一种新的微生物组分层系统可预测支气管扩张症的未来恶化。
Ann Am Thorac Soc. 2014 May;11(4):496-503. doi: 10.1513/AnnalsATS.201310-335OC.
3
Non cystic fibrosis bronchiectasis: A longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance.非囊性纤维化支气管扩张症:铜绿假单胞菌持续存在与耐药性的纵向回顾性观察队列研究
Respir Med. 2015 Jun;109(6):716-26. doi: 10.1016/j.rmed.2014.07.021. Epub 2014 Aug 29.
4
Yield of sputum microbiological examination in patients hospitalized for exacerbations of chronic obstructive pulmonary disease with purulent sputum.因慢性阻塞性肺疾病急性加重伴脓性痰住院患者的痰微生物学检查结果
Respiration. 2007;74(1):19-25. doi: 10.1159/000093158. Epub 2006 May 3.
5
Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重的微生物学决定因素
Arch Intern Med. 2005 Apr 25;165(8):891-7. doi: 10.1001/archinte.165.8.891.
6
The clinical significance of Haemophilus influenzae and H. parainfluenzae isolated from the sputum of adult patients at an urban general hospital.从一家城市综合医院成年患者痰液中分离出的流感嗜血杆菌和副流感嗜血杆菌的临床意义。
S Afr Med J. 1992 May 16;81(10):495-8.
7
Sputum bacteriology in steady-state bronchiectasis in Guangzhou, China.中国广州稳定期支气管扩张症患者痰液细菌学研究
Int J Tuberc Lung Dis. 2015 May;19(5):610-9. doi: 10.5588/ijtld.14.0613.
8
[Pseudomonas aeruginosa colonisation in bronchiectatic patients and clinical reflections].
Tuberk Toraks. 2006;54(4):355-62.
9
The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.大环内酯类药物长期治疗对非囊性纤维化支气管扩张症患者呼吸微生物群组成的影响:来自随机、双盲、安慰剂对照 BLESS 试验的分析。
Lancet Respir Med. 2014 Dec;2(12):988-96. doi: 10.1016/S2213-2600(14)70213-9. Epub 2014 Oct 14.
10
Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients.长期、低剂量阿奇霉素治疗可降低丹麦囊性纤维化(CF)患者金黄色葡萄球菌的感染发生率,但会增加其对大环内酯类药物的耐药性。
J Cyst Fibros. 2009 Jan;8(1):58-62. doi: 10.1016/j.jcf.2008.09.001. Epub 2008 Oct 11.

引用本文的文献

1
Clinical Impacts of Isolation in Patients with Bronchiectasis: Findings from KMBARC Registry.支气管扩张症患者隔离的临床影响:来自KMBARC注册研究的结果
J Clin Med. 2024 Aug 24;13(17):5011. doi: 10.3390/jcm13175011.
2
Lung microbiome: new insights into bronchiectasis' outcome.肺部微生物组:对支气管扩张症结局的新认识。
Front Cell Infect Microbiol. 2024 Jun 4;14:1405399. doi: 10.3389/fcimb.2024.1405399. eCollection 2024.
3
Clinical outcomes of long-term inhaled combination therapies in patients with bronchiectasis and airflow obstruction.
支气管扩张和气流阻塞患者长期吸入联合治疗的临床结局。
BMC Pulm Med. 2024 Jan 23;24(1):49. doi: 10.1186/s12890-024-02867-4.
4
Microbiology sampling in non-cystic fibrosis bronchiectasis cases from northern Alberta.阿尔伯塔省北部非囊性纤维化支气管扩张症病例的微生物采样。
PLoS One. 2023 Jul 14;18(7):e0288704. doi: 10.1371/journal.pone.0288704. eCollection 2023.
5
Coexistence of COVID-19, Pseudomonas, and thoracic actinomycosis in a cystic bronchiectasis case.囊性支气管扩张症病例中 COVID-19、铜绿假单胞菌和胸放线菌共存。
BMC Infect Dis. 2023 Apr 6;23(1):203. doi: 10.1186/s12879-023-08215-x.
6
Insights into Personalised Medicine in Bronchiectasis.支气管扩张症个性化医疗的见解
J Pers Med. 2023 Jan 10;13(1):133. doi: 10.3390/jpm13010133.
7
Anti-Aspergillus fumigatus IgG in patients with bronchiectasis and its relationship with clinical outcome.支气管扩张症患者的抗烟曲霉 IgG 及其与临床结局的关系。
Arch Microbiol. 2022 Nov 24;204(12):728. doi: 10.1007/s00203-022-03345-3.
8
A clinicians' review of the respiratory microbiome.临床医生对呼吸道微生物群的综述。
Breathe (Sheff). 2022 Mar;18(1):210161. doi: 10.1183/20734735.0161-2021. Epub 2022 Apr 5.
9
Advances in diagnostic tools for respiratory tract infections: from tuberculosis to COVID-19 - changing paradigms?呼吸道感染诊断工具的进展:从结核病到2019冠状病毒病——范式正在改变?
ERJ Open Res. 2022 Sep 12;8(3). doi: 10.1183/23120541.00113-2022. eCollection 2022 Jul.
10
Impact of Chronic Bronchial Infection by on Bronchiectasis.[病原体名称]慢性支气管感染对支气管扩张的影响。 (注:原文中“by”后面缺少具体病原体名称)
J Clin Med. 2022 Jul 7;11(14):3960. doi: 10.3390/jcm11143960.